CORD-19:0329e0f2e3b8ab0eabe2afe0e5214cc88c61080e / 32857-33080 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T175","span":{"begin":0,"end":223},"obj":"Sentence"},{"id":"T66105","span":{"begin":0,"end":223},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Thus, the increased mutation rates observed in response to favipiravir treatment are unlikely to be due to the incorporation of favipiravir into viral RNA followed by elongation, similar to ribavirin or acyclovir (Fig. 5) ."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T175","span":{"begin":0,"end":223},"obj":"Sentence"}],"text":"Thus, the increased mutation rates observed in response to favipiravir treatment are unlikely to be due to the incorporation of favipiravir into viral RNA followed by elongation, similar to ribavirin or acyclovir (Fig. 5) ."}

{"project":"Epistemic_Statements","denotations":[{"id":"T46","span":{"begin":0,"end":218},"obj":"Epistemic_statement"}],"text":"Thus, the increased mutation rates observed in response to favipiravir treatment are unlikely to be due to the incorporation of favipiravir into viral RNA followed by elongation, similar to ribavirin or acyclovir (Fig. 5) ."}